NEW YORK (GenomeWeb News) – Real Time Genomics today announced a $5 million investment for the expansion of its commercial operations.

Steve Lombardi, CEO of Real Time Genomics, declined to identify who the investor is. The San Bruno, Calif.-based genomics analytics firm said that it comprises cash and the conversion of debt. The funding will be used for sales and marketing and for genomics applications development.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.